Pharmaceuticals / Drugs

Dr. Tiana Tilli

Dr. Tiana Tilli

Clinical Pharmacist and Lecturer

Collaborative team-based primary care, pharmacy practice, pharmacy services for First Nations clients, health promotion, opioid stewardship, immunizations, minor ailments and contraception prescribing, pharmacy benefits for First Nations clients, PharmaCare Plan W, complex medication management

Dr. Aslam Anis, PhD, FCAHS

Dr. Aslam Anis, PhD, FCAHS

Professor and Director pro tem, School of Population and Public Health

Director, Centre for Health Evaluation and Outcome Sciences (CHÉOS)

National Director, CIHR Canadian HIV Trials Network (CTN)

Health economics, pharmacoeconomics, pharmaceutical pricing & policy, population and public health, productivity measurement, HIV/AIDS, marginalized populations, addiction, rheumatoid arthritis, pharmacare,

Bob Hancock

Professor, Microbiology & Immunology

Director, Centre for Microbial Diseases & Immunity Research

Antibiotics, new antimicrobial treatments, boosting immunity, antibiotic resistance, genomics, cystic fibrosis, biotechnology, drug development

Raymond Lam, MD, FRCPC

Professor

BC Leadership Chair in Depression Research

Seasonal affective disorder, winter depression, antidepressants, light therapy, depression, clinical guidelines, circadian rhythms, melatonin, serotonin, dopamine, noradrenaline, tryptophan, cognition, technology, eHealth, mHealth, guidelines, biomarkers, diagnosis, internet, mental illness

Chris Orvig

Professor

Medicinal inorganic chemistry, coordination chemistry of biological and medical relevance, coordination chemistry of the early transition metals, the lanthanides, and the actinides, main group bioinorganic chemistry (particularly group 13), role of metal ions in Alzheimer’s Disease and other neurological dysfunctions, metal complexes as nuclear medicine imaging and therapeutic agents, and as antitumour agents, technetium and rhenium chemistry, radiopharmaceutical chemistry, vanadium compounds as anti-diabetic agents, lanthanide coordination and bioinorganic chemistry

Evan Wood, MD, PhD, ABIM, FRCPC

Professor

Injection drug use, population health, epidemiology, urban health, HIV/AIDS, antiretroviral therapy, addiction, opioids, fentanyl

Prof. Helen Tremlett, PhD

Prof. Helen Tremlett, PhD

Professor & Canada Research Chair in Neuroepidemiology and Multiple Sclerosis

multiple sclerosis, epidemiology, pharmacoepidemiology, health administrative data, drug safety and effectiveness, disease-modifying drugs for multiple sclerosis, gut microbiome, pediatric-onset MS, observational studies, real-world data, post-marketing research,

Artem Cherkasov, PhD

Associate Professor

Drug design, bioinformatics, molecular modeling, proteomics, artificial intelligence, machine learning, antibiotics

James Wright, MD, PhD, FRCP(C)

Professor, Departments of Anesthesiology, Pharmacology & Therapeutics and Medicine

Co-Managing Director and Chair, Therapeutics Initiative

Prescription drugs, evidence-based medicine, high blood pressure, drug trials

Larry Lynd, BSP, PhD

Larry Lynd, BSP, PhD

Professor

Director, Collaboration of Outcomes Research and Evaluation (CORE)

Health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases

Marco Ciufolini, PhD

Professor & Canada Research Chair

Organic chemistry, heterocyclic chemistry, medicinal chemistry, organic synthesis, synthetic methodology, natural products

Michael Curry, LLB/JD, MD, CCFP(EM), FCLM, FCFP

Michael Curry, LLB/JD, MD, CCFP(EM), FCLM, FCFP

Clinical Associate Professor

Emergency medicine, emergency room, emergency doctor, emergency physician, stroke, heart attack, trauma, accident, illness, influenza, superbug, MRSA, E coli, medicolegal, medical legal, medical law, legal medicine, medical ethics, health care ethics, malpractice, ethics, doctor, coronavirus,

Prof. Judy Wong, PhD

Prof. Judy Wong, PhD

Professor

cancer biology, aging, genetics, pharmacology, telomere, telomerase, G-quadruplex,

Dr. Mahyar Etminan, PharmD, MSc

Dr. Mahyar Etminan, PharmD, MSc

Associate Professor

Drug Safety, Pharmacoepidemiology, Adverse Drug Reaction, COVID-19, COVID-19 vaccine safety and efficacy, Epidemiology,

Urs Hafeli, PhD

Urs Hafeli, PhD

Associate Professor

Magnetic targeting, drug delivery, radiopharmaceuticals, imaging, microspheres, pharmaceutics, nanotechnology

Christian Kastrup, PhD

Assistant Professor

Hemorrhage, coagulation, biomaterials, nanomedicine, platelets, blood, combat casualty care, clots, bleeding

Brian Warriner, MD

Clinical Professor

All aspects of anesthesia practice – drugs, effects, monitoring, pharmacology, physiology, respiratory function, cardiac function, operative assessment, anesthesia for different disease processes, airway management, addiction in anesthetists, opioids, fentanyl

Gavin Stuart, MD, FRCSC, FCAHS

Professor

Gynecologic oncology, cancer, health care administration, clinical trials, medical education

Kate Smolina

Kate Smolina

Adjunct Professor

Linked health administrative data, chronic disease surveillance, public health monitoring and reporting, health system performance measurement, pharmacoepidemiology, prescription opioids

Abby Collier, PhD

Professor

Drugs in children, drugs in pregnancy, developmental pharmacology, drug metabolism, pharmacokinetics